{
    "Trade/Device Name(s)": [
        "Virtuoso\u2122M System for IHC ER (SP1)",
        "Virtuoso\u2122M System for IHC (SP1) with Benchmark ULTRA stainer"
    ],
    "Submitter Information": "Ventana Medical Systems, Inc. Digital Pathology",
    "510(k) Number": "K140465",
    "Predicate Device Reference 510(k) Number(s)": [
        "K130515"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NOT",
        "NQN",
        "OEO"
    ],
    "Summary Letter Date": "February 21, 2014",
    "Summary Letter Received Date": "February 24, 2014",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 864.1860"
    ],
    "Regulation Name(s)": [
        "Immunohistochemistry reagents and kits"
    ],
    "Analyte Class(es)": [
        "anatomic pathology"
    ],
    "Analyte(s)": [
        "Estrogen receptor (ER) protein"
    ],
    "Specimen Type(s)": [
        "Formalin-fixed, paraffin-embedded neoplastic tissue"
    ],
    "Specimen Container(s)": [
        "Glass slide"
    ],
    "Instrument(s)/Platform(s)": [
        "Ventana iScan slide scanner",
        "Computer",
        "Monitor",
        "Benchmark ULTRA stainer"
    ],
    "Method(s)/Technology(ies)": [
        "Digital image analysis",
        "Immunohistochemistry (IHC)",
        "Manual microscopy",
        "DAB chromogen visualization"
    ],
    "Methodologies": [
        "Image analysis",
        "Computer-assisted scoring",
        "Manual verification by pathologist"
    ],
    "Submission Type(s)": [
        "System",
        "Accessory",
        "Software",
        "Analyzer",
        "Reagent",
        "Stainer"
    ],
    "Document Summary": "FDA 510(k) summary for the Virtuoso\u2122M System for IHC ER (SP1) with Benchmark ULTRA stainer, a digital pathology and image analysis system assisting in the detection and measurement of estrogen receptor protein in breast cancer tissue.",
    "Indications for Use Summary": "Aids pathologists in digital display, detection, semi-quantitative measurement, and review of estrogen receptor protein in formalin-fixed, paraffin-embedded neoplastic tissue; adjunctive to CONFIRM anti-Estrogen Receptor (ER) (SP1) assay in assessing breast cancer patients for endocrine treatment consideration.",
    "fda_folder": "Hematology"
}